# Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers

> **NCT05408091** · PHASE1 · COMPLETED · sponsor: **Trellis Bioscience LLC** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TRL345, a human monoclonal antibody

## Key facts

- **NCT ID:** NCT05408091
- **Lead sponsor:** Trellis Bioscience LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-14
- **Primary completion:** 2024-12-23
- **Final completion:** 2024-12-23
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05408091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05408091, "Study to Evaluate Safety and Activity of TRL345 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05408091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*